Task: Answer the multiple-choice question.
Query: Which drug exhibits a 16.875% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) Cc1ccccc1CCNC(=O)CCn1nc(C)c2c(C)n(-c3ccccc3)nc2c1=O
b.) Cc1cccc(N=Nc2c(C)[nH]n(C(N)=S)c2=O)c1C
c.) Cc1ccc(CNC(=O)N2CCN(c3ccc(C)cc3)CC2)cc1
d.) CC(=O)c1ccc(N2CCN(S(=O)(=O)c3c(C)[nH]c(=O)[nH]c3=O)CC2)cc1
e.) Cc1ccc(NC(=O)Cc2nnc(SCC(=O)Nc3nncs3)n2C)cc1
Answer: c. Cc1ccc(CNC(=O)N2CCN(c3ccc(C)cc3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(CNC(=O)N2CCN(c3ccc(C)cc3)CC2)cc1
Cc1ccc(CNC(=O)N2CCN(c3ccc(C)cc3)CC2)cc1
4-(4-methylphenyl)-N-[(4-methylphenyl)methyl]piperazine-1-carboxamide